JenniferFosterMDMPH

Pediatric Hematology & Oncology • Houston, TX

Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology, Clinical Pharmacology

Associate Professor, Pediatrics, Baylor College of Medicine

Join to view full profile

Dr. Foster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Foster's full profile

Already have an account?

Office
6701 Fannin St
Suite 1510.21
Houston, TX 77030
Phone+1 832-824-4646

Education & Training

Baylor College of MedicineMS, 2013 - 2015
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
University of WashingtonResidency, Pediatrics, 2007 - 2010
University of Hawaii, John A. Burns School of MedicineClass of 2007

Certifications & Licensure

TX State Medical License 2013 - 2026
HI State Medical License 2010 - 2016
WA State Medical License 2007 - 2010
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Clinical PharmacologyClinical Pharmacology

Clinical Trials

Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Start of enrollment: 2014 Jan 01
Completed
Not Applicable
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2018 Jan 11
Active, not recruiting
Phase 1
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs Start of enrollment: 2022 Aug 31
Active, not recruiting
Phase 2
Roles: Principal Investigator

Publications & Presentations

PubMed

24 citations
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma.
Ling Tao, Mahmoud A Mohammad, Giorgio Milazzo, Myrthala Moreno-Smith, Tajhal D Patel
Nature Communications. 2022-06-28
162 citations
Molecular targeting therapies for neuroblastoma: Progress and challenges.
Atif Zafar, Wei Wang, Gang Liu, Xinjie Wang, Wa Xian
Medicinal Research Reviews. 2021-03-01
53 citations
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Ami V Desai, Giles W Robinson, Karen Gauvain, Ellen M Basu, Margaret E Macy
Neuro-Oncology. 2022-10-03

Lectures

Phase 1 study of pevonedistat (MLN4924) in combination with temozolomide (TMZ) and irinotecan (IRN) in pediatric patients with recurrent or refractory solid tumors (AD...
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019

Press Mentions

Opioid Crisis Sparks Push to Return to 'Fundamentals of Pain Management'June 30th, 2021
Texas Girl Surprised with Super Bowl Tickets After Being Treated for Rare CancerFebruary 2nd, 2017
Texas Children's Cancer Center Alex's Lemonade Stand Center of ExcellenceSeptember 23rd, 2018

Committees

Member, American Academy of Pediatrics Committee on Drugs 2017 - Present